ATE309352T1 - Inhibitoren der nf-kb aktivierung - Google Patents

Inhibitoren der nf-kb aktivierung

Info

Publication number
ATE309352T1
ATE309352T1 AT99924594T AT99924594T ATE309352T1 AT E309352 T1 ATE309352 T1 AT E309352T1 AT 99924594 T AT99924594 T AT 99924594T AT 99924594 T AT99924594 T AT 99924594T AT E309352 T1 ATE309352 T1 AT E309352T1
Authority
AT
Austria
Prior art keywords
inhibitors
kappab
activation
ikappab
traf
Prior art date
Application number
AT99924594T
Other languages
German (de)
English (en)
Inventor
Rudi Beyaert
Karen Heyninck
Walter Fiers
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of ATE309352T1 publication Critical patent/ATE309352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99924594T 1998-05-06 1999-05-05 Inhibitoren der nf-kb aktivierung ATE309352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201472 1998-05-06
PCT/BE1999/000055 WO1999057133A2 (en) 1998-05-06 1999-05-05 Inhibitors of nf-kb activation

Publications (1)

Publication Number Publication Date
ATE309352T1 true ATE309352T1 (de) 2005-11-15

Family

ID=8233686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924594T ATE309352T1 (de) 1998-05-06 1999-05-05 Inhibitoren der nf-kb aktivierung

Country Status (9)

Country Link
US (2) US6673897B1 (enExample)
EP (1) EP1075519B1 (enExample)
JP (1) JP2002513552A (enExample)
AT (1) ATE309352T1 (enExample)
AU (1) AU754434B2 (enExample)
CA (1) CA2328483A1 (enExample)
DE (1) DE69928244T2 (enExample)
ES (1) ES2251831T3 (enExample)
WO (1) WO1999057133A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1075519B1 (en) 1998-05-06 2005-11-09 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Inhibitors of nf-kb activation
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
AU2002350412B2 (en) * 2001-06-22 2006-06-15 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Abin-mediated hepatitis protection
US7700553B2 (en) 2003-09-24 2010-04-20 Institut Pasteur Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization
WO2006029981A1 (en) * 2004-09-13 2006-03-23 Vib Vzw Abin-mediated protection against lung inflammatory disease
CN1304418C (zh) * 2005-02-22 2007-03-14 中国人民解放军第三军医大学第三附属医院 核因子－κB p65亚基拮抗肽及其应用
WO2006108844A1 (en) * 2005-04-14 2006-10-19 Vib Vzw Treatment of egfr dependent tumors by abin (a20-binding inhibitor of nf kappab)
CA2667972A1 (en) * 2006-10-30 2008-05-08 Michael Tovey Gene reporter assay, kit and cells with improved sensitivity and/or specificity for determining the level of an extracellular signal
CN101307094B (zh) * 2008-03-21 2011-09-28 中国人民解放军第三军医大学第三附属医院 一种核因子-κB p65亚基拮抗多肽
CN101798336B (zh) * 2009-02-06 2012-02-29 中国人民解放军第三军医大学第三附属医院 一种具有示踪功能的抗肿瘤化合物
CN111606976A (zh) * 2020-05-26 2020-09-01 中国人民解放军军事科学院军事医学研究院 一种小肽及其在抑制阿片成瘾性和耐受性上的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) * 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) * 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) * 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) * 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) * 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) * 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
EP1075519B1 (en) 1998-05-06 2005-11-09 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Inhibitors of nf-kb activation

Also Published As

Publication number Publication date
WO1999057133A3 (en) 2000-02-24
DE69928244D1 (de) 2005-12-15
DE69928244T2 (de) 2006-08-10
AU754434B2 (en) 2002-11-14
WO1999057133A2 (en) 1999-11-11
JP2002513552A (ja) 2002-05-14
CA2328483A1 (en) 1999-11-11
US7414026B2 (en) 2008-08-19
US6673897B1 (en) 2004-01-06
ES2251831T3 (es) 2006-05-01
AU4124499A (en) 1999-11-23
EP1075519A2 (en) 2001-02-14
EP1075519B1 (en) 2005-11-09
US20040092430A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
EP1009415A4 (en) INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DE69939864D1 (de) Ppar-gamma modulatoren
DK0739212T3 (da) Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
ATE253383T1 (de) Behandlung von in der luft enthaltenen mikroorganismen
ES2191830T3 (es) Inhibidores de trombina.
DE69928244D1 (de) Inhibitoren der nf-kb aktivierung
DE69836209D1 (de) Vorbeugung und behandlunhg des hepatozellulären krebses
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE69826282D1 (de) Handgelenkband zur vermeidung und behandlung des karpaltunnelsyndroms
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
NO980296D0 (no) Forbedrede terapeutiske midler
ES2186807T3 (es) Inhibidores de trombina.
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
TR200002939T2 (tr) Paroksetin maleat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1075519

Country of ref document: EP

REN Ceased due to non-payment of the annual fee